Sign Up for Our E-Newsletter

What’s Happening?

Top 4 Takeaways: ASCO Annual Meeting

Posted on June 10, 2014

cancer screening

We recently had the privilege of attending the 2014 American Society for Clinical Oncology Annual Meeting where 35,000 scientists, researchers, medical professionals and advocates from around the world gathered to share cutting-edge scientific innovations and connect with other industry professionals. We sat in on some truly inspirational meetings and presentations that shed light on what’s to come in the area of cancer research. Miss the live updates that weekend? No worries. Check out these need-to-know takeaways from our Patient Advocate Medical Consultant Dr. Laura Porter and get educated on what’s on the horizon for our community. Read more

My Story: Personalized Chemo Dosing

Posted on June 8, 2014

serum tube (2)

“I didn’t think I was doing that badly, but apparently I was losing ground and the side effects were getting worse.”

After nearly 11 years of ongoing health issues, my energy was fading fast. I’d seen doctor after doctor, specialist after specialist, but no one seemed to know what was wrong. By chance, I remembered that I’d had a colonoscopy back in 2000 and they’d found a polyp. I brought this up to my doctor and, combined with my symptoms, he scheduled me for a repeat colonoscopy. Read more

Webinar: Better Cancer Care Through Accurate and Personalized Chemotherapy Dosing

Posted on June 5, 2014

girl at comp

Learn how to achieve the ideal concentration of chemotherapy drug in your system through our upcoming webinar. We’re partnering with MyCare Diagnostics to bring you a discussion on better cancer care featuring Adrienne Choma, Co-founder and Chief Operating Officer of Saladax Biomedical Inc., the maker of My5-FU Chemotherapy Optimization Test.  Read more

Partner Spotlight: Abramson Cancer Center

Posted on June 3, 2014


The Partnership

In 2012 we were proud to name the Abramson Cancer Center at the University of Pennsylvania as a partner through our Blue Hope Partnership Program, an initiative providing funding to organizations that are making strides to knock colon cancer out of the top three cancer killers. Abramson Cancer Center is made up of a group of doctors and researchers who, through treatment and prevention, are working to eradicate cancer as a cause of human disease and suffering. Funds provided through our Blue Hope Partnership Program were put to use in 2012 when Abramson launched the University of Pennsylvania Health System’s Colorectal Cancer Screening Navigation Program. Read more

Colon Health Alert: FDA Approves First-Line Use of Vectibix®

Posted on May 28, 2014

Colon Health Alert_square

Amgen recently announced that the FDA has approved the use of Vectibix as a first-line treatment for colorectal cancer. Since 2006, Vectibix has been used as a second-line treatment and with this recent advancement, colorectal cancer patients now have an additional treatment option earlier in their diagnosis. Read more